2022
DOI: 10.1016/j.cmpb.2021.106590
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptomics and machine learning to advance schizophrenia genetics: A case-control study using post-mortem brain data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…The AutoML technique was implemented for applying various classifiers to determine the laterality of seizure onset in FLE using HRV parameters as input features (He et al, 2021 ; Qi et al, 2022 ). Four frequency domain (i.e., VLF, LF, HF, and LF/HF ratio) and six time domain HRV parameters (i.e., mean NN interval, SDNN, RMSSD, SDSD, pNN20, and pNN50) were utilized as input features.…”
Section: Methodsmentioning
confidence: 99%
“…The AutoML technique was implemented for applying various classifiers to determine the laterality of seizure onset in FLE using HRV parameters as input features (He et al, 2021 ; Qi et al, 2022 ). Four frequency domain (i.e., VLF, LF, HF, and LF/HF ratio) and six time domain HRV parameters (i.e., mean NN interval, SDNN, RMSSD, SDSD, pNN20, and pNN50) were utilized as input features.…”
Section: Methodsmentioning
confidence: 99%
“…Using data from the iPSYCH2012 case cohort, another study integrated genetics and registry data with a deep learning approach to stratify 19,636 patients with schizophrenia and/or major depressive disorder into clinically distinct subgroups, characterized by unique disorder severities and comorbidity signatures, with predictive models achieving AUCs of 0.55 to 0.97, and therefore emphasized the importance of data-driven stratification for improving psychiatric diagnosis and prognosis [40]. Similarly, Qi and colleagues analyzed gene expression datasets from untreated schizophrenia patients and controls, identified 14 key gene probes, and used artificial NN to achieve diagnostic accuracy of 91.2% in training and 87.9% in testing and highlighted the potential of machine learning in identifying clinically useful biomarkers for schizophrenia [41]. Another study introduced a sparse deep NN approach for identifying interpretable features for schizophrenia casecontrol classification using gray matter volume and single nucleotide polymorphism data, demonstrating slightly improved performance over traditional methods, and highlighting key brain regions related to the schizophrenia [42].…”
Section: Predicting Schizophreniamentioning
confidence: 99%